Comparative evaluation of chemiluminescence immunoassay and immunochromatograhic test with ELISA for detection of HCV infection

https://doi.org/10.53730/ijhs.v6nS9.13195

Authors

  • Liya K Shaji Postgraduate student, JSS Academy of Higher Education and Research, Mysuru
  • Sujatha S R Senior Resident, Department of Microbiology, JSS Medical College and Hospital, Mysuru
  • Deepashree R Assistant Professor, Department of Microbiology, JSS Medical College and Hospital, Mysuru
  • Tejashree. A Professor & Head, Department of Microbiology, JSS Academy of Higher Education and Research, Mysuru, India
  • Satyasai. B Tutor, Department of Microbiology, JSS Medical College and Hospital, Mysuru

Keywords:

HCV- Hepatitis C virus, ELISA- Enzyme linked immunosorbent assay, CLIA- chemiluminescent immunoassay, ICT- immunochromatographic test

Abstract

Introduction: Hepatitis C virus still remains the major concern of post-transfusion viral infection causing chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. Serological detection of anti-HCV IgG antibody is the mainstay for diagnosis of HCV. Enzyme linked immunosorbent assay (ELISA) is one of the commonest method used. Other screening test include chemiluminescent immunoassay (CLIA) and immunochromatographic test (ICT). This was a prospective laboratory based study conducted with the aim to assess anti-HCV detection method like ICT, CLIA, and ELISA with reliable sensitivity and specificity. Material and methods: A total of 92 samples that were received for routine HCV antibody detection to the microbiology laboratory were subjected to CLIA, ELISA and ICT simultaneously taking Elisa as gold standard & comparative evaluation was done. Results: Out of 92 samples, CLIA showed 34 (37%) reactive and 58 (63%) non-reactive. Whereas, ELISA and ICT showed 30 (32.6%) positive and 62 (67.3%) negative results. Conclusion: The results of CLIA & ICT was comparable with results of ELISA. CLIA had a sensitivity and specificity of 96.6% and 91.9%, ICT had a sensitivity and specificity of 98.38% and 96.6% accordingly, when compared to ELISA.

Downloads

Download data is not yet available.

References

Ali N, Batool Z, Noor A, Aurangzeb, Khan SA, Basharat S. Immunochromatography and chemiluminescence for detection of anti hcv antibodies in diagnosis of hepatitis C infection among healthy blood donors. J Med Sci. 2018;26(4):268–71.

Lindenbach BD, Rice CM. Unravelling hepatitis C virus replication from genome to function. Nature. 2005;436(7053):933–8.

Verónica Saludes, Victoria González, Ramon Planas, Lurdes Matas, Vicente Ausina, Elisa Martró: Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging world journal of gastroenterology; April 7, 2014|Volume 20

Val Hebron, Homie A Razavi: Hepatitis C virus infection; https://www.researchgate.net/publication/31419271Article in March 2017 DOI: 10.1038/nrdp.2017.6

Trowbridge R, Sloots TP, Buda P, Faoagali J, Hyland C, Young I, et al. tis C virus : use in diagnosis and analysis of indeterminate samples. J Hepatol [Internet]. 1996;24(5):532–8. Available from: http://onlinelibrary.wiley.com/o/

Majumder, Pampi, Shetty, Anup; Comparison between ELISA and chemiluminescence immunoassay for the detection of Hepatitis C virus antibody: 2017/01/01 DOI 10.18231/2394- 5478.2017.00781

Cloherty G, Talal A, Coller K, Steinhart C, Hackett J, Dawson G, et al. Role of serologic and molecular diagnostic assays in identification and management of hepatitis c virus infection. J Clin Microbiol. 2016;54(2):265–73.

Kasem A, Azeem K, Vlčková J, Zatloukalová S, Štěpánek L, Kyselý Z, et al. Epidemiology of hepatitis e virus infection. Epidemiol Mikrobiol Imunol.

Ekta Gupta, Meenu Bajpai, Aashish Choudhary : Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays; DOI: 10.4103/0973-6247.126683

Kamili S, Drobeniuc J, Araujo AC, Hayden TM. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis. 2012;55 Suppl 1(Suppl 1):43–8.

Dufour DR, Talastas M, Fernandez MDA, Harris B. Chemiluminescence assay improves specificity of hepatitis C antibody detection. Clin Chem. 2003;49(6):940–4. 81

Patel J, Sharma P. Design of a novel rapid immunoassay for simultaneous detection of hepatitis C virus core antigen and antibodies. Arch Virol [Internet]. 2020;165(3):627–41. Available from: https://doi.org/10.1007/s00705-019-04518-0

Ghaderi-Zefrehi H, Sharafi H, Sadeghi F, Gholami-Fesharaki M, Farasat A, Jahanpeyma F, et al. Seroprevalence of hepatitis C virus among blood donors in middle eastern countries: A systematic review and meta-analysis. Iran Red Crescent Med J. 2017;19(12):1–11.

Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, et al. Consensus statement of HCV task force of the Indian National Association for Study of the Liver (INASL). Part I: Status report of HCV infection in India. J Clin Exp Hepatol [Internet]. 2014;4(2):106–16. Available from: http://dx.doi.org/10.1016/j.jceh.2014.05.006

Kumari HP, Vijayalakshmi P. Comparison of two rapid immunoassays for screening of hcv infection in dialysis patients. 2017;(December).

Walewska-Zielecka B, Religioni U, Juszczyk G, Wawrzyniak ZM, Czerw A, Soszyński P, et al. Anti-hepatitis C virus seroprevalence in the working age population in Poland, 2004 to 2014. Eurosurveillance. 2017;22(2).

Ali I, Siddique L, Rehman LU, Khan NU, Iqbal A, Munir I, et al. Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa. Virol J [Internet]. 2011;8(1):296. Available from: http://www.virologyj.com/content/8/1/296

Sk J, Nurahmed N, Kebede S, Getahun M, Arega T, Am A. Prevalence of hepatitis B and C viruses infections among hemodialysis patients in Addis Ababa, Ethiopia. J Interv Nephrol. 2018;1(1):8–14.

Article O. Performance Evaluation of Blood Donor Screening Assays for Serological Detection of Hepatitis B Surface Antigen and Antibodies to Hepatitis C Virus. 2021;205–10.

Naz A, Mukry SN, Naseer I, Shamsi TS. Evaluation of efficacy of serological methods for detection of HCV infection in blood donors: A single centre experience. Pakistan J Med Sci. 2018;34(5):1204–8.

Khan A, Tareen AM, Ikram A, Rahman H, Wadood A, Qasim M, et al. Prevalence of HCV among the young male blood donors of Quetta region of Balochistan, Pakistan. Virol J. 2013;10:2–5.

Kumar, S. (2022). A quest for sustainium (sustainability Premium): review of sustainable bonds. Academy of Accounting and Financial Studies Journal, Vol. 26, no.2, pp. 1-18

Allugunti V.R (2022). Breast cancer detection based on thermographic images using machine learning and deep learning algorithms. International Journal of Engineering in Computer Science 4(1), 49-56

Viswanatha KKRC, Reddy A, Elango N M (2019). Diabetes Kaggle Dataset Adequacy Scrutiny using Factor Exploration and Correlation, International Journal of Recent Technology and Engineering (IJRTE) Vol. 8.

Zameer M, Shazad F, Saeed M, Aziz S, Nazish, Hussain S. Comparison Between Elisa and Ict Techniques for the Detection of Anti Hcv Antibody Among Blood Donors. Biomedica. 2016;32(4):281–4

Muthiah KP, Susitha T. Role of Rapid Test and ELISA in the Diagnosis of HCV in Haemodialysis Patients. Int J Curr Microbiol Appl Sci. 2017;6(1):362–6.

Khudur Al-Nassary MS, Mahdi BM. Study of Hepatitis C Virus Detection Assays. Ann Med Surg [Internet]. 2018;36(May):47–50. Available from: https://doi.org/10.1016/j.amsu.2018.10.002

Published

02-10-2022

How to Cite

Shaji, L. K. ., Sujatha, S. R., Deepashree, R., Tejashree, A., & Satyasai, B. (2022). Comparative evaluation of chemiluminescence immunoassay and immunochromatograhic test with ELISA for detection of HCV infection. International Journal of Health Sciences, 6(S9), 3044–3053. https://doi.org/10.53730/ijhs.v6nS9.13195

Issue

Section

Peer Review Articles

Most read articles by the same author(s)